Acute anterior myocardial infarction due to aortosaphenous vein graft occlusion with very large thrombus burden

Experimental and Clinical Cardiology

Volumn 12, Issue 4, 2007, Pages 203-205

  Bitigen, Atilla ^a   Gurel, Emre ^a,c   Tanalp, Ali Cevat ^b   Aung, Soe Moe ^a   Başaran, Yelda ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b Yuzuncu Yil Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Anterior MI; Aortosaphenous vein graft occlusion; Infarct

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; HEPARIN; METOPROLOL; PLASMINOGEN ACTIVATOR; RAMIPRIL; TIROFIBAN; WARFARIN;

AGED; ANAMNESIS; ARTERY CATHETERIZATION; ARTICLE; BOLUS INJECTION; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; ELECTROCARDIOGRAPHY; GRAFT OCCLUSION; HEART REINFARCTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; ST SEGMENT ELEVATION; VASCULAR PATENCY;

EID: 37549032098     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-4.
2. Singh M, Rosenschein U, Ho KK, Berger PB, Kuntz R, Holmes DR Jr. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: A randomized study (ATLAS). Circulation 2003;107:2331-6.
3. Shah RA, Khanal S, Kugelmass A. Spontaneous late thrombolysis of an occluded saphenous vein graft subsequent to acute myocardial infarction treated with percutaneous coronary intervention to the native culprit vessel. J Interv Cardiol 2006;19:178-82.
4. Nguyen TT, O'Neill WW, Grines CL, et al. One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. Am J Cardiol 2003;91:1250-4.
5. Al Suwaidi J, Velianou JL, Berger PB, et al. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J 2001;142:452-9.
6. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998;97:916-31.
7. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89:248-58.
8. Fitzgibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol 1991;17:1075-80.
9. Baim DS, Wahr D, George B, et al; Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
10. Sezer M, Oflaz H, Gören T, et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med 2007;356:1823-34.
11. Abbas AE, Brewington SD, Dixon SR, Boura JA, Grines CL, O'Neill WW. Intracoronary fibrin-specific thrombolytic infusion facilitates percutaneous recanalization of chronic total occlusion. J Am Coll Cardiol 2005;46:793-8.
12. Natarajan D, Rai VN, Jain A, Roy T, Sharma PK, Nigam PD. Intracoronary versus intravenous streptokinase in acute myocardial infarction. Int J Cardiol 1988;19:181-9.
13. Robinson N, Barakat K, Dymond D. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart 1999;81:434-7.
14. Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit. Ann Intern Med 2005;143:241-50.